Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

MHRA issues warning over heavy metals in unlicensed Chinese medicines

Practice A number of unlicensed traditional Chinese medicines have been found to contain dangerously high levels of metals, leading the MHRA to issue a warning to the public not to buy them over the internet

The MHRA has warned the public against buying a number of unlicensed traditional Chinese medicines used to treat infections and fever in young children over the internet because they contain dangerously high levels of lead, mercury and arsenic.


Tests by the Swedish National Food Agency had found "extremely high" levels of arsenic in medicines used to treat mumps, sore throat, tonsillitis, toothache, skin infections, anorexia and fever in young children, the MHRA reported today (August 20). The products are called Niu-Huang Chieh-tu-pein, Divya Kaishore Guggul and Chandraprabha Vati.


In addition, the Hong Kong government had recalled Bak Foong Pills, used to treat menstrual pain, because it found that the product contained twice the level of lead allowed by the Hong Kong authorities, the MHRA said. It had also recalled Hairegenerator, a product used to treat hair loss, because tests found 11 times the permitted level of mercury in a sample of the medicine.


The public should use "extreme caution" when buying traditional Chinese medicines over the internet, says the MHRA

More on the MHRA

MHRA issues warning over faulty diabetes strips

MHRA mulls reclassifying diclofenac as a POM

MHRA recalls 16 POMs after contamination fears at Indian factory

MORE NEWS

The MHRA stressed that none of the products were authorised for sale in the UK. It warned the public to use "extreme caution" when buying unlicensed medicines because standards varied greatly and were not been assessed for safety or quality. "The adulteration of traditional Chinese medicines with heavy metals is a significant international problem and can pose a serious risk to public health," said MHRA head of policy Richard Woodfield.


Patients who think they may have taken any of the products needed to speak to their doctor and report any side effects through the Yellow Card scheme, he said.


UK-authorised herbal products, which are subject to safety monitoring, were registered under the MHRA's Traditional Herbal Registration scheme and have the THR registration number or logo on the packaging, he added.



Have you encountered any problems with customers taking unlicensed drugs?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016453

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel